作者:
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞系, 肿瘤(Cell Line, Tumor);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);人类(Humans);咪唑啉啶类(Imidazolidines);吲哚类(Indoles);MAP激酶信号系统(MAP Kinase Signaling System);黑色素瘤(Melanoma);小鼠(Mice);小鼠, SCID(Mice, SCID);突变(Mutation);丁酸苯酯类(Phenylbutyrates);磷酰化(Phosphorylation);原癌基因蛋白质类(Proto-Oncogene Proteins);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);原癌基因蛋白质c-raf(Proto-Oncogene Proteins c-raf);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));信号传导(Signal Transduction);磺胺类(Sulfonamides);转染(Transfection);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays);ras蛋白质类(ras Proteins)
DOI
10.1158/0008-5472.CAN-11-1875
PMID
22205714
发布时间
2022-03-16
- 浏览27

Cancer research
969-78页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文